(Q32067234)

English

Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 July 2017

Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor (English)

1 reference

Europe PubMed Central

6 July 2017

anticoagulation

1 reference

based on heuristic

inferred from title

prothrombin complex concentrate

1 reference

based on heuristic

inferred from title

author name string

M Elg

1

1 reference

Europe PubMed Central

6 July 2017

S Carlsson

2

1 reference

Europe PubMed Central

6 July 2017

D Gustafsson

3

1 reference

Europe PubMed Central

6 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2001

1 reference

Europe PubMed Central

6 July 2017

Thrombosis Research

1 reference

Europe PubMed Central

6 July 2017

101

1 reference

Europe PubMed Central

6 July 2017

3

1 reference

Europe PubMed Central

6 July 2017

145-157

1 reference

Europe PubMed Central

6 July 2017

The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of recombinant factor VIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of recombinant human FVIIA on warfarin-induced bleeding in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Factor VIII and DDAVP reverse the effect of recombinant desulphatohirudin (CGP 39393) on bleeding in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human factor VIIa (rFVIIa) in a rabbit stasis model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Factor VII and activated-factor-VII content of prothrombin complex concentrates. The PCC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900397-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0049-3848(00)00397-2

1 reference

Europe PubMed Central

6 July 2017

1 reference

Europe PubMed Central

6 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32067234&oldid=2042055439"